| abstract |
The present disclosure is directed, in part, to compounds and methods for imaging mycardial perfusion, comprising administering to a patient a contrast agent such as of Formula lIl (see formula III) which comprises a compound that binds MC-1 and an imaging moiety, and scanning the patient using diagnostic imaging, such as MRI, ultrasound imaging, fluorescence imaging and optical imaging. |